BioSpace News Archive

iECURE today announced that it has expanded its management team by adding two experienced industry executives into key roles within the organization.

Skye Bioscience, Inc. announced that in a preclinical study assessing the neuroprotective properties of its SBI-100 ophthalmic nanoemulsion, the treated group demonstrated a trend of retaining greater function of the eye’s retinal ganglion cells.

Jaguar Health, Inc. (NASDAQ:JAGX) and Napo Pharmaceuticals, the company’s wholly owned subsidiary, today announced the completion of a third-party, investigator-initiated preclinical enterocyte.

NEOGEN Corporation (NASDAQ: NEOG) announced today that it has added a new chemiluminescent substrate as part of the trusted K-Blue® product line.

Shineco, Inc., a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that the Company has appointed Professor Qiyin Sun as the Chief Medical Consultant.

Clover Biopharmaceuticals, Ltd., a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, announced the appointment of Nicholas Jackson, Ph.D., as President of Global Research and Development.

Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), today announced the upcoming podium presentation of the latest interim analysis from the ALIGN3D™ clinical study at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.8% in the company’s quarterly cash dividend, beginning in the first quarter of 2022.

Pfizer Inc. and BioNTech SE announced that following a request from the U.S. Food and Drug Administration the companies have initiated a rolling submission seeking to amend the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine to include children 6 months through 4 years of age, in response to the urgent public health need in this population.

Kronos Bio, Inc. today announced the appointment of Dr. Elizabeth Olek, DO, MPH, as senior vice president, Clinical Development.